Switch to:
More From Other Websites
Ligand Partner GSK Announces Record Quarterly Promacta™/Revolade™ Revenue of $92 Million Jul 23 2014
Ligand Partner GSK Announces Record Quarterly Promacta™/Revolade™ Revenue of $92 Million Jul 23 2014
Ligand Partner SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 to... Jul 22 2014
Ligand Partner SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 to... Jul 22 2014
Lemelson Capital Management Announces TTM and Second Quarter 2014 Performance Results for The Amvona... Jul 17 2014
Ligand Reports Second Quarter Revenues and Announces Share Repurchase Program Jul 17 2014
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 17 2014
Ligand board authorizes $10M repurchase program Jul 17 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide